Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

WHAT'S NEW

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jun 29 2026 UPDATED 9:19 AM

Full Issue

Shingles Vaccine May Help Protect Against Dementia

Experts think the reduction in brain inflammation, caused by the reactivation of the varicella-zoster virus in the body, might help protect against dementia. Patients in nursing facilities showed a 5.8% lower risk of developing dementia over the next four years after receiving at least one shot of the shingles vaccine, NBC News reports.

NBC News: Shingles Is Linked To Inflammation In The Brain. Research Shows How To Cut Dementia Risk

The shingles vaccine may significantly help protect older adults against dementia, a growing body of evidence shows. Exactly how is unclear. The nervous system, however, likely holds clues. Shingles, a condition triggered by the reactivation of the varicella-zoster virus in the body, can cause a “war zone” of inflammation in the brain, said Dr. Jennifer Pauldurai, the medical director of the Inova Brain Health and Memory Disorders Program in Northern Virginia. (Leake, 6/28)

More pharmaceutical developments —

The Hill: Oral GLP-1 Pill Delivers Nearly 12% Weight Loss In 36 Weeks, Study Finds

Patients taking the oral GLP-1 drug aleniglipron saw up to a 12 percent reduction in body weight after 36 weeks, according to researchers. The study, conducted at Northwestern University, found the drug stimulates insulin secretion, suppresses appetite and increases satiety to promote weight loss. “The difference with aleniglipron is it’s a small molecule, meaning it’s chemically made and can be taken with or without food,” said Dr. Robert Kushner, a co-author of the study and a professor at Northwestern. (Taub, 6/28)

MedPage Today: Taste, Smell Disturbances Seen In GLP-1 Users

Use of GLP-1 receptor agonists was associated with a higher risk of smell and taste disturbances among adults with type 2 diabetes, an analysis of electronic health record (EHR) data suggested. (Monaco, 6/26)

NPR: Could Pepcid AC And Allergy Pills Help With PMS Symptoms?

People who feel extra rotten in the days leading up to their period say they're finding relief from a new TikTok trend. It's a combination of two over-the-counter drugs: An allergy pill, like Claritin or Zyrtec, along with Pepcid AC, the heartburn medication. It might sound unbelievable, but after dealing with years of unexplained symptoms, Terese Hansen of Omaha, Nebraska was willing to try almost anything. (Boden, 6/29)

KFF Health News: Reporters Talk Through FDA Sunscreen Move And Closure Of Rural Dialysis Clinics

KFF Health News freelance contributor Michael Scaturro discussed the FDA’s new approval of a sunscreen chemical on Science Friday on June 19. (6/27)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 29
  • Friday, June 26
  • Thursday, June 25
  • Wednesday, June 24
  • Tuesday, June 23
  • Monday, June 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF